Table 1 from Idiopathic Pulmonary Fibrosis. | Semantic Scholar
IJMS | Free Full-Text | Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5 | HTML
New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis | Scientific Reports
Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory Medicine
Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text
Survival analysis for total IPF patients according to GAP stage with... | Download Scientific Diagram
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review | European Respiratory Society
overview of major clinical trials undertaken in ipF. | Download Table
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: Executive Summary
Summary of patient classification according to disease diagnosis and... | Download Scientific Diagram
Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study | PLOS ONE
Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports
Drug Interactions With Interstitial Lung Disease Pharmacotherapy
The genetic basis of idiopathic pulmonary fibrosis | European Respiratory Society
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity - eBioMedicine
Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients | Scientific Reports
![PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c684687c72bb1328cdf9cccadf8b1d961f766ebd/3-Table2-1.png "PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar")
PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar
Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment - eClinicalMedicine
Summary of finding form Pirfenidone for idiopathic pulmonary fibrosis. | Download Table
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar
